Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative

J Poleszczuk1, P Hahnfeldt, H Enderling

  • 1Center of Cancer Systems Biology, GRI, Tufts University School of Medicine, Boston, MA, 02135, USA; College of Inter-faculty Individual Studies in Mathematics and Natural Sciences, University of Warsaw, Warsaw, 02-089, Poland.

Cell Proliferation
|March 27, 2014
PubMed
Abstract

Insights

Reactivating cell senescence in non-stem cancer cells can initially increase tumor size but ultimately controls tumor growth by limiting cancer stem cell activity, inhibiting malignant progression.

Area of Science:

  • Cellular biology
  • Cancer research
  • Computational modeling

Background:

  • Cell senescence is a natural process of irreversible cell cycle arrest that prevents damaged cells from dividing, acting as a tumor suppressor mechanism.
  • Cancer cells often evade senescence to promote malignancy, but recent research indicates senescence can be re-induced in cancer cells.
  • The cancer stem-cell hypothesis suggests that a subpopulation of cancer stem cells drives tumor growth, while other cancer cells (CCs) may impede this process.

Purpose of the Study:

  • To investigate the role of intratumoral competition between cancer stem cells and non-stem cancer cells (CCs) in tumor progression.
  • To model how the reactivation of replicative senescence in CCs influences tumor dynamics and cancer presentation risk.

Main Methods:

  • Development of an agent-based model simulating solid tumor growth.
  • Model inputs are based on the cancer stem-cell hypothesis, incorporating dynamics between cancer stem cells and non-stem cancer cells (CCs).
  • Simulations were performed to analyze the effects of reactivated senescence in CCs on tumor progression.

Main Results:

  • Reactivation of replicative senescence in CCs initially leads to increased total tumor burden due to reduced cell death.
  • Over the long term, this senescence reactivation curtails tumor growth by imposing constraints on the cancer stem cell compartment.
  • Intratumoral competition between cell types modulates tumor progression and influences the risk of cancer presentation.

Conclusions:

  • Reactivating replicative senescence in non-stem cancer cells prolongs their competition with cancer stem cells.
  • This prolonged competition ultimately inhibits malignant progression, irrespective of the initial tumor size.
  • Senescence reactivation emerges as a potential strategy for long-term tumor control.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K